David D. Waters

Regression of coronary atherosclerosis: an achievable goal? Review of results from recent clinical trials.

D. Waters, J. Lespérance, J. Lésperance, 1991, The American journal of medicine.

Design features of a controlled clinical trial to assess the effect of an HMG CoA reductase inhibitor on the progression of coronary artery disease. Canadian Coronary Atherosclerosis Intervention Trial Investigators Montreal, Ottawa, and Toronto, Canada.

D. Waters, B. Kimball, L. Higginson, 1993, Controlled clinical trials.

Effects of cholesterol lowering on the progression of coronary atherosclerosis in women. A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) substudy.

D. Waters, L. Higginson, J. Lespérance, 1995, Circulation.